MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

14 hedge funds and large institutions have $987K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$651K -$12.9K -9,453 -2%
Renaissance Technologies
2
Renaissance Technologies
New York
$91K -$20.1K -14,800 -18%
BFM
3
Boothbay Fund Management
New York
$66K -$12.9K -9,453 -16%
Millennium Management
4
Millennium Management
New York
$49K +$49K +35,903 New
Two Sigma Advisers
5
Two Sigma Advisers
New York
$35K +$3.72K +2,700 +12%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$33K +$33K +24,502 New
HF
7
HRT Financial
New York
$26K +$3.1K +2,368 +14%
SBL
8
Sargent Bickham Lagudis
Colorado
$20K
Morgan Stanley
9
Morgan Stanley
New York
$8K
Osaic Holdings
10
Osaic Holdings
Arizona
$4K +$691 +474 +21%
AA
11
AlphaMark Advisors
Kentucky
$3K +$3K +2,306 New
UBS Group
12
UBS Group
Switzerland
$1K -$30.4K -14,820 -97%
BBHC
13
Brown Brothers Harriman & Co
New York
$238
Goldman Sachs
14
Goldman Sachs
New York
-$138K -88,426 Closed
PAM
15
PVG Asset Management
Colorado
-$18.7K -11,988 Closed